Get access to our best features

HIV vaccine candidate induces immune response in early clinical trial: ‘An important step forward’

Summary by Ground News
An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus.
Published 2 months ago · San Jose, United States

News Articles

More Filters
All
Left
Center
Right

HIV vaccine candidate induces immune response in early clinical trial: 'An important step forward'

An experimental HIV vaccine has been found to induce broadly neutralizing antibody precursors among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus.

2 months ago·Atlanta, United States
Read Full Article

HIV vaccine candidate shows early promise

The vaccine, called eOD-GT8 60mer, had a “favorable safety profile” and induced broadly neutralizing antibodies in 97%, or all but one, of the 36 recipients, according to the researcher…

2 months ago·San Jose, United States
Read Full Article

An early-stage HIV vaccine is showing positive results. If it works, it would be first successful HIV vaccine after almost 40 years of research.

An early trial for an experimental HIV vaccine candidate has shown promising results.97% of recipients in a phase 1 study showed immune system activity in

2 months ago·United States
Read Full Article

Vaccine prompts HIV antibodies in 97 per cent of people in small study

An experimental HIV vaccine led to antibodies against the virus in 35 out of 36 volunteers, but whether this offers protection against the infection is unclear

2 months ago·Baltimore, United States
Read Full Article

HIV vaccine candidate induces immune response in early clinical trial: 'An important step forward'

An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune…

2 months ago·Huntsville, United States
Read Full Article

HIV vaccine candidate induces immune response in early clinical trial

An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study.

2 months ago·Flint, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

50% of the sources lean Left, 50% of the sources are Center
CNN
The Mercury news
Business Insider
Global Citizen
NewScientist
waaytv.com
abc12/WJRT
Science
L 50%
C 50%
See less detail